Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-002167
Filing Date
2008-03-31
Accepted
2008-03-31 11:20:06
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS b68187aie10vk.htm 10-K 1120246
2 EX-10.29 NON-EMPLOYEE DIRECTOR COMPENSATION COMPANY b68187aiexv10w29.htm EX-10.29 8023
3 EX-10.30 EXECUTIVE OFFICER COMPENSATION SUMMARY b68187aiexv10w30.htm EX-10.30 9641
4 EX-21 SUBSIDIARIES OF THE REGISTRANT b68187aiexv21.htm EX-21 2675
5 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b68187aiexv23w1.htm EX-23.1 1657
6 EX-23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b68187aiexv23w2.htm EX-23.2 1541
7 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68187aiexv31w1.htm EX-31.1 8808
8 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68187aiexv31w2.htm EX-31.2 10352
9 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68187aiexv32w1.htm EX-32.1 3176
10 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68187aiexv32w2.htm EX-32.2 3916
  Complete submission text file 0000950135-08-002167.txt   1171743
Mailing Address 85 MAIN STREET HOPKINTON MA 01748
Business Address 85 MAIN STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

EIN.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-06533 | Film No.: 08722281
SIC: 2834 Pharmaceutical Preparations